SCHEMBL5435367

SCHEMBL5435367

CC(C)C[C@@H](C(N)=O)N(CCCNS(=O)(=O)c1ccc(F)cc1Cl)C(=O)CCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 1/20 0.40
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CCR1 P32246 1/20 0.36
ADAM17 P78536 1/20 0.36
FABP4 P15090 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
PRSS1 P07477 2/20 0.34
F10 P00742 1/20 0.34
PRSS2 P07478 1/20 0.34
PRSS3 P35030 1/20 0.34
TRPV4 Q9HBA0 2/20 0.34
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4140703 0.91 TRPV4 (0.37) BMP1CCR1ADAM17ALDH1A1TRPV4
SCHEMBL4141257 0.91 CCR1 (0.41) BMP1CCR1ADAM17ALDH1A1PRSS1
SCHEMBL4145546 0.91 CCR1 (0.35) BMP1CCR1ADAM17ALDH1A1TDP1
SCHEMBL4141037 0.89 BMP1 (0.37) BMP1CCR1ADAM17FABP4TRPV4
SCHEMBL5439390 0.88 BMP1 (0.36) BMP1MEN1KMT2ACCR1ADAM17
SCHEMBL4130362 0.87 POLB (0.34) BMP1MEN1KMT2ACCR1ADAM17
SCHEMBL5438950 0.86 BMP1 (0.35) BMP1CCR1ADAM17ALDH1A1KDM4E
SCHEMBL5439621 0.85 CCR1 (0.38) BMP1CCR1ADAM17ALDH1A1MAPK1
SCHEMBL4136278 0.84 BMP1 (0.39) BMP1MEN1KMT2ACCR1ADAM17
SCHEMBL5434779 0.83 CCR1 (0.38) BMP1CCR1ADAM17ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259965-A1 Acyclic 1,3-Diamine And Uses Therefor SMITHKLINE BEECHAM CORPORATION 2007-11-08 US claimed
US-20070259965-A1 Acyclic 1,3-Diamine And Uses Therefor SMITHKLINE BEECHAM CORPORATION 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259965-A1 Acyclic 1,3-Diamine And Uses Therefor TRPV4, TRPC4, TRPV1 BMP1 1833/4885MEN1 1683/4885KMT2A 3582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.